2 December
Pure Biologics establishes the Doto Medical special purpose vehicle and signs an agreement with the renowned international business advisor Clairfield Partners to accelerate the commercialization of the PB103 aptamer project.
31 March
Pure Biologics has published its annual report for 2021 in which it summarizes its financial results and scientific achievements.
Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers